• Accueil >
  • Publications >
  • Poor performance status patient with long-lasting major response to pembrolizumab in advanced non-small-cell lung cancer with coexisting POLE mutation and deficient mismatch repair pathway

Poor performance status patient with long-lasting major response to pembrolizumab in advanced non-small-cell lung cancer with coexisting POLE mutation and deficient mismatch repair pathway

1 oct. 2021Lung Cancer

DOI : 10.1016/j.lungcan.2021.07.016

Auteurs

Charles Vauchier, Johan Pluvy, Nathalie Theou-Anton, Ghassen Soussi, Nicolas Poté, Solenn Brosseau, Valérie Gounant, Gérard Zalcman